The Campbell’s Company (CPB) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Oct, 2026Executive summary
FY2026 net sales were $9.744B, down 5% vs. FY2025; adjusted EBIT was $1.181B, down 21%, and adjusted EPS was $2.17, down 27%.
Strategy prioritizes U.S. everyday cooking and snacking, consumer-led brands, and enterprise transformation to support profitable growth.
Voting matters and shareholder proposals
Shareholders will vote Nov. 17, 2026, on 12 director nominees for one-year terms; the Board recommends FOR each nominee.
The Board recommends FOR PwC as auditor for FY2027, FOR advisory approval of FY2026 executive pay, and FOR the amended and restated 2022 LTIP.
The Board recommends AGAINST a shareholder request for a report on regenerative agriculture effectiveness, including pesticide-reduction outcomes.
Board of directors and corporate governance
11 of 12 nominees are independent, including the independent Board Chair; all four standing committees are fully independent.
Four nominees are women and three are ethnically diverse; four new independent directors have joined since 2020, with average independent-director tenure of 8.6 years.
In FY2026, the director retirement age rose from 72 to 75, subject to a limited Board waiver; directors attended at least 90% of Board and committee meetings.
Governance safeguards include annual director elections, majority voting in uncontested elections, shareholder written-consent and special-meeting rights, and no shareholder rights plan.
Latest events from The Campbell’s Company
- Transformation plan targets margin recovery, leverage reduction, and brand-focused growth.CPB
Barclays 19th Annual Global Consumer Conference - Earnings and sales fell, dividend was cut, and a major cost savings plan was announced.CPB
Q4 2026 (Q&A) - Earnings and sales fell as inflation persisted; cost savings and dividend cut target debt reduction.CPB
Q4 2026 Prepared Remarks - Board elections, financials, and all management proposals approved; shareholder proposals rejected.CPB
AGM 2025 - Sales and earnings fell sharply, leading to a more cautious outlook and accelerated cost savings.CPB
Q2 2026 Prepared remarks - Net sales and earnings declined, but guidance and premium brands remain resilient.CPB
Q3 2026 Prepared remarks - Net sales fell 4% and margins declined, but cost savings and guidance were maintained.CPB
Q3 2026 (Q&A) - Sales and earnings declined, but cost savings and new partnerships support reaffirmed guidance.CPB
Q1 2026 - Net sales rose 9% but organic sales and adjusted EPS declined, prompting lower guidance.CPB
Q2 2025